Pharmafile Logo

Cuttsy+Cuttsy’s first EcoVadis rating comes back silver!

Louise Jones, Sustainability Officer at Cuttsy+Cuttsy celebrates their new silver sustainability rating

Over the past year we have been making practical steps to align Cuttsy+Cuttsy to a more sustainable future. Earlier this month, we completed our first voluntary assessment as part of this goal. EcoVadis is a sustainability ratings provider who partner with companies to supply a globally recognised scorecard and performance improvement tools. The submission required a thorough audit across many of our operations, processes, and carbon footprint.

The results are in and Cuttsy+Cuttsy now rate among the top 25 percent of companies assessed by EcoVadis, scoring us a Silver accreditation. As our first submission, this is slightly mind-blowing.

To say I am over the moon would be an understatement. The team and I have worked incredibly hard, and our commitment to sustainability has clearly been reflected. We are incredibly proud of this score, and we are already working on the objectives to achieve Gold.

We are firm believers in better health for everyone and this cannot be achieved without also considering the health of our planet. This is just the first voluntary disclosure we have conducted this year, there will be plenty more to come. Watch this space.

Cuttsy+Cuttsy are committed to a net zero future, and we will achieve this through accurate carbon disclosures and verifiable science-based targets. We will accomplish this, and I look forward to the day when we announce ‘WE DID IT’.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Clinical trial considerations: Why supporting HCPs matters...

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trial considerations: Why diversity matters...

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Clinical trial considerations: Why digital matters...

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Clinical trials explained: Why imagery matters...

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Clinical trials explained: Why health literacy matters...

Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...

Clinical trials explained: Why iconography matters...

Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial...

Cuttsy+Cuttsy appoints Harriet Karia as Managing Director

Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.

Using generative AI in healthcare comms - our promise to our clients

It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when...